Proteomic analysis of calcified abdominal and thoracic aortic aneurysms

International Journal of Molecular Medicine

Volumn 30, Issue 2, 2012, Pages 417-429

  Matsumoto, Ken Ichi ^a   Maniwa, Tomoko ^a   Tanaka, Tetsuya ^b   Satoh, Kazumi ^a   Okunishi, Hideki ^b   Oda, Teiji ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Calcified abdominal aortic aneurysm; Calcified thoracic aortic aneurysm; Isobaric tag for absolute and relative quantitation; Proteomics

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BETA2 GLYCOPROTEIN 1; BIGLYCAN; BLOOD CLOTTING FACTOR 9; CARBOXYPEPTIDASE B; CATHEPSIN D; CLUSTERIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COMPLEMENT COMPONENT C9; ERYTHROCYTE BAND 3 PROTEIN; FETUIN A; FIBRINOGEN; FIBULIN 5; HEMOGLOBIN BETA CHAIN; HISTONE H4; INTEGRIN; MIMECAN; PROTHROMBIN; SERUM AMYLOID A; SERUM AMYLOID P; VITRONECTIN;

ABDOMINAL AORTA ANEURYSM; AMINO ACID SEQUENCE; ARTERY CALCIFICATION; ARTICLE; BLOOD CLOTTING; CALCIFIED ABDOMINAL AORTA ANEURYSM; CALCIFIED THORACIC AORTA ANEURYSM; CLINICAL ARTICLE; GLYCOLYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; THORACIC AORTA ANEURYSM;

AORTA; AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; HUMANS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

EID: 84863553778     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.985     Document Type: Article

References (45)

1. Annambhotla S, Bourgeois S, Wang X, Lin PH, Yao Q and Chen C: Recent advances in molecular mechanisms of abdominal aortic aneurysm formation. World J Surg 32: 976-986, 2008.
2. Galis ZS and Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90: 251-262, 2002.
3. Kuivaniemi H, Platsoucas CD and Tilson III MD: Aortic aneurysms: an immune disease with a strong genetic component. Circulation 117: 242-252, 2008.
4. Abdul-Hussien H, Soekhoe RG, Weber E, et al: Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 170: 809-817, 2007.
5. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J and Libby P: Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99: 96-104, 1999.
6. Golledge J, Muller J, Daugherty A and Norman P: Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 26: 2605-2613, 2006.
7. Reed D, Reed C, Stemmermann G and Hayashi T: Are aortic aneurysms caused by atherosclerosis? Circulation 85: 205-211, 1992.
8. Ruddy JM, Jones JA, Spinale FG and Ikonomidis JS: Regional heterogeneity within the aorta: relevance to aneurysm disease. J Thorac Cardiovasc Surg 136: 1123-1130, 2008.
9. Lesauskaite V, Tanganelli P, Sassi C, et al: Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol 32: 1003-1011, 2001.
10. Coady MA, Rizzo JA, Goldstein LJ and Elefteriades JA: Natural history, pathogenesis, and etiology of thoracic aortic aneurysms and dissections. Cardiol Clin 17: 615-635, 1999.
11. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF and Schwartz RS: Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92: 2157-2162, 1995.
12. Shanahan CM: Mechanisms of vascular calcification in renal disease. Clin Nephrol 63: 146-157, 2005.
13. Lehto S, Niskanen L, Suhonen M, Rönnemaa T and Laakso M: Medial artery calcification. A neglected harbinger of cardiovas cular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16: 978-983, 1996.
14. Rusanescu G, Weissleder R and Aikawa E: Notch signaling in cardiovascular disease and calcification. Curr Cardiol Rev 4: 148-156, 2008.
15. Kendrick J and Chonchol M: The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis 58: 826-834, 2011.
16. Didangelos A, Yin X, Mandal K, et al: Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol Cell Proteomics 10: M111.008128, 2011.
17. Tung WS, Lee JK and Thompson RW: Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array. J Vasc Surg 34: 143-150, 2001.
18. Absi TS, Sundt III TM, Tung WS, et al: Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 126: 344-357, 2003.
19. Ross PL, Huang YN, Marchese JN, et al: Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169, 2004.
20. Matsumoto K: Phosphorylation of extracellular matrix tenascin-X detected by differential mass tagging followed by nanoLC-MALDITOF/TOF-MS/MS using ProteinPilot software. Connect Tissue Res 53: 106-116, 2012.
21. Shilov IV, Seymour SL, Patel AA, et al: The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6: 1638-1655, 2007.
22. Sturn A, Quackenbush J and Trajanoski Z: Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208, 2002.
23. Wang X, LeMaire SA, Chen L, et al: Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 114 (Suppl 1): I200-I205, 2006.
24. Touat Z, Lepage L, Ollivier V, et al: Dilation-dependent activa tion of platelets and prothrombin in human thoracic ascending aortic aneurysm. Arterioscler Thromb Vasc Biol 28: 940-946, 2008.
25. Wang X, LeMaire SA, Chen L, et al: Decreased expression of fibulin-5 correlates with reduced elastin in thoracic aortic dissec tion. Surgery 138: 352-359, 2005.
26. Wallin R, Wajih N, Greenwood GT and Sane DC: Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev 21: 274-301, 2001.
27. Jensen LT and Høst NB: Collagen: scaffold for repair or execution. Cardiovasc Res 33: 535-539, 1997.
28. Nakamura T, Lozano PR, Ikeda Y, et al: Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415: 171-175, 2002.
29. Rezg R, Barreto FC, Barreto DV, Liabeuf S, Drüeke TB and Massy ZA: Inhibitors of vascular calcification as potential thera peutic targets. J Nephrol 24: 416-427, 2011.
30. Spronk HM, Soute BA, Schurgers LJ, et al: Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun 289: 485-490, 2001.
31. Krauss RM and Kesäniemi YA: Cardiovascular disease and hyperlipidaemia. Curr Opin Lipidol 5: 249-251, 1994.
32. Golledge J, van Bockxmeer F, Jamrozik K, McCann M and Norman PE: Association between serum lipoproteins and abdominal aortic aneurysm. Am J Cardiol 105: 249-251, 2010.
33. Greenow K, Pearce NJ and Ramji DP: The key role of apolipo protein E in atherosclerosis. J Mol Med 83: 329-342, 2005.
34. Walldius G and Jungner I: The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med 259: 493-519, 2006.
35. Tailleux A, Duriez P, Fruchart JC and Clavey V: Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 164: 1-13, 2002.
36. Stan S, Delvin E, Lambert M, Seidman E and Levy E: Apo A-IV: an update on regulation and physiologic functions. Biochim Biophys Acta 1631: 177-187, 2003.
37. Kawakami A and Yoshida M: Apolipoprotein CIII links dyslip idemia with atherosclerosis. J Atheroscler Thromb 16: 6-11, 2009.
38. Sadek M, Hynecek RL, Goldenberg S, Kent KC, Marin ML and Faries PL: Gene expression analysis of a porcine native abdominal aortic aneurysm model. Surgery 144: 252-258, 2008.
39. Michel JB, Martin-Ventura JL, Egido J, et al: Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 90: 18-27, 2011.
40. Stec JJ, Silbershatz H, Tofler GH, et al: Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 102: 1634-1638, 2000.
41. McCormick ML, Gavrila D and Weintraub NL: Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 27: 461-469, 2007.
42. Grote K, Flach I, Luchtefeld M, et al: Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92: e80-e86, 2003.
43. Dubick MA, Hunter GC, Casey S and Keen CL: Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med 184: 138-143, 1987.
44. Stephens JW, Bain BC and Humphries SE: Gene-environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis 200: 229-238, 2008.
45. Sukhanov S, Higashi Y, Shai SY, et al: Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase. Circ Res 99: 191-200, 2006.